NME3 anticorps (AA 51-81)
-
- Antigène Voir toutes NME3 Anticorps
- NME3 (NME/NM23 Nucleoside Diphosphate Kinase 3 (NME3))
-
Épitope
- AA 51-81
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp NME3 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Purification
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- Immunogène
- This NME3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 51-81 amino acids from the Central region of human NME3.
- Clone
- RB5454
- Isotype
- Ig Fraction
- Top Product
- Discover our top product NME3 Anticorps primaire
-
-
- Indications d'application
- WB: 1:1000. IHC-P: 1:50~100
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
- Date de péremption
- 6 months
-
- Antigène
- NME3 (NME/NM23 Nucleoside Diphosphate Kinase 3 (NME3))
- Autre désignation
- NME3 (NME3 Produits)
- Synonymes
- anticorps DR-nm23, anticorps NDPK-C, anticorps NDPKC, anticorps NM23-H3, anticorps NM23H3, anticorps c371H6.2, anticorps 1810009F08Rik, anticorps AI413736, anticorps Ndk3, anticorps Nm23-DR, anticorps Nm23-M3, anticorps NME/NM23 nucleoside diphosphate kinase 3, anticorps NME3, anticorps Nme3
- Sujet
- NME3 mRNA is preferentially expressed at early stages of myeloid differentiation of highly purified CD34(+) cells. Its constitutive expression in a myeloid precursor line, which is growth-factor dependent for both proliferation and differentiation, results in inhibition of granulocytic differentiation induced by granulocyte colony-stimulating factor and causes apoptotic cell death. These results appear consistent with a role for the NME3 gene in normal hematopoiesis and raise the possibility that its overexpression contributes to differentiation arrest, a feature of blastic transformation in chronic myelogenous leukemia.
- Poids moléculaire
- 19015
- ID gène
- 4832
- NCBI Accession
- NP_002504
- UniProt
- Q13232
- Pathways
- Nucleotide Phosphorylation, Ribonucleoside Biosynthetic Process
-